{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-024730","form_type":"8-K","ticker":"WAT","cik":"0001000697","company_name":"WATERS CORP /DE/","filed_at":"2025-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.623021+00:00","generated_at":"2026-05-26T22:35:43.339971+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Waters Q4 sales $873M beat guidance; non-GAAP EPS $4.10 up 13% YoY; FY2025 EPS guide $12.70-$13.00","bullets":["Q4 sales $873M, +6% reported / +8% constant currency; exceeded high-end of guidance range.","Non-GAAP EPS $4.10 (+13% YoY); GAAP EPS $3.88; FX headwind ~9% in Q4.","Full-year sales $2,958M (flat); non-GAAP EPS $11.86 (+1%); operating cash flow $762M; free cash flow $744M (25% of sales).","FY2025 guidance: constant currency sales growth +4.5%–7.0%; non-GAAP EPS $12.70–$13.00; Q1 non-GAAP EPS $2.17–$2.25.","Pharma sales +10% constant currency; instruments +8%, recurring +9% constant currency in Q4."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-024730","json":"https://secwatch.observer/filing/0001193125-25-024730.json","markdown":"https://secwatch.observer/filing/0001193125-25-024730.md","text":"https://secwatch.observer/filing/0001193125-25-024730.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1000697/000119312525024730/0001193125-25-024730-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1000697/000119312525024730/d904971d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:35:43.339971+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}